ENDO 2006 offers breaking research on the metabolic syndrome, obesity, hormones in women and more

This year's annual meeting of The Endocrine Society, ENDO 2006, is packed with appearances from powerful medical leaders from top medical associations plus the latest scientific developments as the world's leading endocrinologists gather to unravel medical mysteries and debate some of medicine's most highly controversial topics.

In addition to releasing breaking science on topics such as the controversial Metabolic Syndrome, male osteoporosis, endocannabinoids (the agent in marijuana that causes the "munchies") and new drug therapies for obesity, ENDO 2006 will feature:

  • Presentation from NIH Director, Dr. Elias Zerhouni entitled, "NIH at the Crossroads: Myths, Realities and Strategies for the Future"
  • Highly controversial debate on the existence, treatment and causes of the Metabolic Syndrome from presidents of the American Heart Association and the American Diabetes Association, representatives from the FDA and the pharmaceutical industry
  • The Hormone Foundation round table on Menopause Management with national experts
  • And the results of three clinical trials covering treatments of female sexual dysfunction, growth hormone therapy in children and hyperparathyroidism.

This year's press schedule will feature highlights of the scientific program through a combination of expert sessions and media round tables designed to give journalists opportunity for in-depth conversations with the experts. For a complete press schedule, to speak with a presenter or to obtain a free press registration form, please contact Meghan Norville at (410) 821-8220 or meghann@imrecommunications.com.


Contact: Tadu Yimam
The Endocrine Society & The Hormone Foundation

Page: 1

Related biology news :

1. UCF nanoparticle offers promise for treating glaucoma
2. Lucky 13 as new gene discovery offers further hope for childhood blindness
3. Largest synthetic gene ever built offers insights into anti-malarial drug resistance
4. Gene therapy offers new hope for treatment of peripheral neuropathy
5. Study of protein folds offers insight into metabolic evolution
6. Soy estrogens and breast cancer: Researcher offers overview
7. NIST building software offers green product advice
8. Study of planarians offers insight into germ cell development
9. Nanotechnology offers hope for treating spinal cord injuries, diabetes and Parkinsons disease
10. Research on grey mold offers possible breakthrough in tomato cultivation
11. RNA enzyme structure offers a glimpse into the origins of life

Post Your Comments:

(Date:5/16/2017)... TEANECK, N.J. , May 16, 2017  Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... analysis platform specifically designed for life science researchers to analyze and interpret ... Rosalind Franklin, who made a major contribution to the discovery of the ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back ... 8th June 2018 in San Francisco, CA. The Summit brings together current and former ... CEOs, board directors and government officials from around the world to address key issues ...
(Date:10/11/2017)... , ... October 11, 2017 , ... Disappearing forests and ... lives of over 5.5 million people each year. Especially those living in larger cities ... Treepex - based in one of the most pollution-affected countries globally - decided to ...
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
Breaking Biology Technology:
Cached News: